🔴 Moleculin Biotech is trading 5.3% down today without a clear company-specific catalyst

Moleculin Biotech is trading 5.3% down now at $0.58, with no new company-specific announcement clearly explaining the August 19, 2026 decline.

• The latest identifiable corporate update was the August 14 second-quarter report, highlighting continued MIRACLE trial progress and positive preliminary efficacy results.
• Trading volume was approximately 373,380 shares versus a 1.3 million-share daily average, suggesting relatively limited activity so far.